CTNM Contineum Therapeutics, Inc.

Fundamentals / CIK 0001855175 / USD

Contineum Therapeutics, Inc. reported $257.0M in total assets and a net loss of $63.46M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CTNM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$55.61M$27.81M$0-$60.33MFY 2023 Revenue: $50.00MFY 2023 Net Income: $22.72M2023FY 2024 Revenue: $0FY 2024 Net Income: -$42.26M2024FY 2025 Net Income: -$59.98M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Revenue -- $0 $50.00M
Research & Development $51.52M $38.42M $27.60M
Total Operating Expenses $68.06M $50.89M $33.92M
Operating Income -$68.06M -$50.89M $16.08M
EBITDA -$67.74M -$50.64M $16.27M
Interest Income $8.25M $8.90M $4.61M
Interest Expense -- $0 $208K
Income Before Tax -$60.14M -$42.26M $23.17M
Income Tax Expense $0 $0 $450K
Net Income -$59.98M -$42.26M $22.72M
Basic EPS -$2.17 -$2.18 $1.36
Diluted EPS -$2.17 -$2.18 $0.08
Basic Shares Outstanding 27.7M 19.4M 2.3M
Diluted Shares Outstanding 27.7M 19.4M 3.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $15.98M $12.70M $11.65M $12.76M $10.99M $14.06M $13.71M $13.02M
Total Operating Expenses $20.97M $17.43M $16.90M $17.11M $14.93M $17.90M $18.11M $17.05M
Operating Income -$20.97M -$17.43M -$16.90M -$17.11M -$14.93M -$17.90M -$18.11M -$17.05M
EBITDA -$20.89M -$17.29M -$16.82M -$17.03M -$14.85M -$17.82M -$18.03M -$16.97M
Interest Income $2.36M $2.34M $2.50M $2.01M $1.96M $2.03M $2.25M $2.53M
Interest Expense -- -- -- -- -- -- -- $0
Income Before Tax -- -- -- -- -- -- -- -$14.56M
Income Tax Expense -- -- -- -- -- -- -- $0
Net Income -$18.70M -$15.15M -$14.46M -$15.16M -$12.79M -$16.04M -$15.99M -$14.56M
Basic EPS -$0.49 -$0.40 -$0.39 -- -$0.45 -$0.62 -$0.62 --
Diluted EPS -$0.49 -$0.40 -$0.39 -- -$0.45 -$0.62 -$0.62 --
Basic Shares Outstanding 38.4M 37.5M 37.3M -- 28.1M 25.9M 25.9M --
Diluted Shares Outstanding 38.4M 37.5M 37.3M -- 28.1M 25.9M 25.9M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $75.60M $21.94M $15.53M
Short-Term Investments $187.3M $182.8M $109.7M
Cash & Short-Term Investments $262.9M $204.8M $125.2M
Total Current Assets $267.9M $206.4M $127.7M
Property, Plant & Equipment, Net $830K $989K $678K
Other Non-Current Assets $256K $3.0K $1.28M
Total Non-Current Assets $8.72M $6.46M $2.68M
Total Assets $276.6M $212.8M $130.4M
Accounts Payable $1.02M $1.81M $635K
Total Current Liabilities $9.74M $9.97M $5.48M
Other Non-Current Liabilities -- $0 $110K
Total Non-Current Liabilities $5.91M $4.81M $218K
Total Liabilities $15.65M $14.78M $5.70M
Total Debt (incl. Leases) $8.25M $6.26M $572K
Common Stock -- -- $2.0K
Retained Earnings -$177.4M -$117.4M -$75.14M
Accumulated Other Comp. Income $260K $71K $108K
Total Stockholders' Equity $261.0M $198.1M -$67.94M
Total Equity $261.0M $198.1M -$67.94M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $75.20M $14.71M $20.16M $75.60M $42.63M $20.78M $22.47M $21.94M
Short-Term Investments $169.3M $221.8M $226.2M $187.3M $139.8M $154.7M $168.2M $182.8M
Cash & Short-Term Investments $244.5M $236.6M $246.3M $262.9M $182.4M $175.5M $190.7M $204.8M
Total Current Assets $249.7M $242.6M $253.0M $267.9M $184.9M $176.8M $192.1M $206.4M
Property, Plant & Equipment, Net $848K $929K $1.06M $830K $880K $856K $891K $989K
Other Non-Current Assets $300K $364K $312K $256K $266K $186K $4.0K $3.0K
Total Non-Current Assets $7.24M $7.79M $8.38M $8.72M $5.92M $6.05M $6.13M $6.46M
Total Assets $257.0M $250.4M $261.3M $276.6M $190.8M $182.9M $198.3M $212.8M
Accounts Payable $641K $505K $1.50M $1.02M $786K $2.00M $3.65M $1.81M
Total Current Liabilities $8.03M $6.53M $6.66M $9.74M $6.36M $7.21M $8.95M $9.97M
Other Non-Current Liabilities -- -- -- -- -- -- -- $0
Total Non-Current Liabilities $3.54M $4.18M $4.65M $5.91M $4.02M $4.28M $4.55M $4.81M
Total Liabilities $11.57M $10.71M $11.31M $15.65M $10.38M $11.50M $13.50M $14.78M
Total Debt (incl. Leases) $6.27M $6.57M $6.95M $8.25M $5.49M $5.75M $6.00M $6.26M
Retained Earnings -$225.7M -$207.0M -$191.8M -$177.4M -$162.2M -$149.4M -$133.4M -$117.4M
Accumulated Other Comp. Income -$1.51M -$573K -$253K $260K $265K $147K $170K $71K
Total Stockholders' Equity $245.4M $239.7M $250.0M $261.0M $180.5M $171.4M $184.8M $198.1M
Total Equity $245.4M $239.7M $250.0M $261.0M $180.5M $171.4M $184.8M $198.1M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$59.98M -$42.26M $22.72M
Depreciation & Amortization $323K $258K $195K
Stock-Based Compensation $10.04M $6.80M $2.22M
Change in Payables -$869K $1.14M $0
Operating Cash Flow -$55.31M -$32.84M $19.35M
Capital Expenditure -$231K -$514K -$414K
Free Cash Flow -$55.54M -$33.36M $18.93M
Purchases of Investments -$162.5M -$226.4M -$141.9M
Investing Cash Flow -$3.71M -$69.74M -$65.57M
Common Stock Issued -- $108.2M $0
Share Repurchases -- $0 -$28K
Financing Cash Flow $112.7M $109.0M $56.18M
Net Change in Cash $53.66M $6.42M $9.96M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$18.70M -$15.15M -$14.46M -$15.16M -$12.79M -$16.04M -$15.99M -$14.56M
Depreciation & Amortization $81K $134K $83K $85K $81K $79K $78K $75K
Stock-Based Compensation $4.86M $3.84M $3.82M $2.48M $2.57M $2.42M $2.57M $2.25M
Change in Payables $136K -$990K $490K $162K -$1.22M -$1.64M $1.83M $378K
Operating Cash Flow -$11.06M -$11.50M -$16.27M -$13.04M -$12.20M -$15.66M -$14.41M -$10.20M
Capital Expenditure $0 -$6.0K -$312K -$42K -$98K -$44K -$47K -$166K
Free Cash Flow -$11.06M -$11.51M -$16.58M -$13.08M -$12.29M -$15.71M -$14.46M -$10.37M
Purchases of Investments -$16.04M -$45.78M -$97.12M -$84.73M -$18.64M -$25.44M -$33.69M -$54.35M
Investing Cash Flow $50.95M $4.85M -$39.31M -$47.45M $14.94M $13.88M $14.91M -$9.39M
Financing Cash Flow $20.59M $1.20M $129K $93.47M $19.11M $91K $24K $642K
Net Change in Cash $60.49M -$5.45M -$55.45M $32.97M $21.85M -$1.69M $527K -$18.95M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Operating Margin -- -- 32.2%
Net Profit Margin -- -- 45.4%
Return on Equity (ROE) -23.0% -21.3% --
Return on Assets (ROA) -21.7% -19.9% 17.4%
Current Ratio 27.50x 20.69x 23.29x
Quick Ratio 26.98x 20.53x 22.83x
Debt to Equity 0.03x 0.03x --
Revenue Growth (YoY) -- -100.0% --
Operating Income Growth (YoY) -- -416.6% --
Net Income Growth (YoY) -- -286.0% --
EPS Growth (YoY) -- -260.3% --
Operating Cash Flow Growth (YoY) -- -269.8% --
Free Cash Flow Growth (YoY) -- -276.2% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -25.9% -24.0% -23.4% -23.0% -32.9% -33.2% -27.0% -21.3%
Return on Assets (ROA) -24.7% -23.0% -22.4% -21.7% -31.1% -31.1% -25.1% -19.9%
Current Ratio 31.11x 37.17x 38.00x 27.50x 29.07x 24.51x 21.47x 20.69x
Quick Ratio 30.46x 36.25x 37.00x 26.98x 28.67x 24.33x 21.31x 20.53x
Debt to Equity 0.03x 0.03x 0.03x 0.03x 0.03x 0.03x 0.03x 0.03x
Source: SEC EDGAR CompanyFacts (CIK 0001855175) · from March 31, 2023 Data through September 30, 2026 · synced Nov 20, 2026, 05:38 UTC · Open in terminal